Australian Rotavirus Surveillance Program : Annual Report, 2017

Susie Roczo-Farkas, Daniel Cowley, Julie E Bines, S Bradbury, E Malinsky, W Rawlinson, M Lahra, J Merif, A Kesson, I Tam, V Sintchenko, T Olna, R Givney, S Pearce, K Delves, D Spence, M Wehrhahn, M Karimi, H Cook, F Moore Show all

Communicable Diseases Intelligence Quarterly Report | AUSTRALIAN GOVERNMENT, DEPT HEALTH & AGEING | Published : 2019


The Australian Rotavirus Surveillance Program together with collaborating laboratories Australia-wide conducts a laboratory based rotavirus surveillance program. This report describes the genotypes of rotavirus strains responsible for the hospitalisation of children with acute gastroenteritis during 1 July 2010 to 30 June 2011. This report represents the fourth year of surveillance following introduction of rotavirus vaccines into the National Immunisation Program. One thousand one hundred and twenty-seven faecal samples were referred to the centre for G and P genotype analysis using hemi-nested multiplex reverse transcription-polymerase chain reaction. Eight hundred and sixteen samples were..

View full abstract


Awarded by GlaxoSmithKline Biologicals SA

Funding Acknowledgements

The Australian Rotavirus Surveillance Program is supported by grants from the Australian Government Department of Health, GlaxoSmithKline Biologicals SA [Study#116120] and Seqirus (bioCSL) Australia. The Murdoch Children's Research Institute (MCRI) is supported by the Victorian Government's Operational Infrastructure Support program. GlaxoSmithKline Biologicals SA was provided the opportunity to review a preliminary version of this manuscript for factual accuracy but the authors are solely responsible for final content and interpretation. The authors received no financial support or other form of compensation related to the development of the manuscript.